Your Anthropic Equity Could Be Worth Millions

This is the most common, and most expensive, question Anthropic employees face. The answer depends on your grant type (ISO vs. NSO), strike price, current cash position, and AMT exposure.

The core tradeoff: Exercising now at a lower FMV means a smaller spread and lower AMT (for ISOs) or lower ordinary income hit (for NSOs). But it requires cash upfront and locks capital into an illiquid asset. Waiting means zero cash outlay today, but the spread between your strike and IPO-day FMV will trigger a much larger tax event.

For early employees with strike prices of $1–10/share, the spread at current valuations already creates significant AMT exposure. If the IPO prices at $500B+, that spread only grows, and so does your tax bill.

The framework: Exercise in tranches across tax years to stay within the AMT-free zone each year. This is the single most effective strategy for ISOs, and it requires planning 1–2 years in advance of your target liquidity event.

ISOs (Incentive Stock Options) are taxed favorably if you meet holding requirements: hold shares for 1 year after exercise and 2 years after grant date to qualify for long-term capital gains rates (20% + 3.8% NIIT) instead of ordinary income rates (37%+ federal). However, the spread at exercise triggers AMT, which can create a cash crunch in years you exercise heavily.

NSOs (Non-Qualified Stock Options) are simpler: the spread at exercise is taxed as ordinary income immediately, with withholding applied. No AMT complexity, but no LTCG benefit either. NSOs are common for contractors, later-stage grants, and situations where ISO limits ($100K annual vesting limit) are exceeded.

Many Anthropic employees hold both. The strategy is to exercise ISOs within the AMT-free zone and time NSO exercises to tax years where your marginal rate is lower, often the year before or after a large liquidity event.

When you exercise ISOs, the spread (FMV minus strike price) is not regular income, but it is an AMT preference item. The AMT system runs a parallel tax calculation: if your AMT liability exceeds your regular tax, you pay the difference.

Example: You exercise 10,000 ISOs with a $5 strike when FMV is $50/share. The spread is $450,000. Under AMT, this adds $450K to your AMT income. At a 28% AMT rate, that's potentially $126,000 in additional tax. That's on shares you can't yet sell.

The critical concept is the AMT-free zone: the amount of ISO spread you can absorb in a given year without triggering additional AMT. This varies based on your W-2 income, deductions, filing status, and state taxes. For most Anthropic employees earning $300K–$500K+ in base salary, the AMT-free zone is often $50K–$150K of spread per year.

The strategy: Exercise in tranches across multiple tax years, staying within the AMT-free zone each year. This approach can save $100K–$300K+ compared to a single large exercise. Our ISO Exercise Calculator models this for your specific situation.

Anthropic has confidentially filed for an IPO at a $965B valuation, with a listing possible as soon as this fall. This is your first significant liquidity event on the horizon, and how you prepare for it sets the foundation for everything that follows.

This isn't an either/or decision. It's a sequencing question. The optimal strategy for most employees involves participating in the tender now and having a post-IPO plan.

Arguments for tendering now: Guaranteed liquidity at a known price. Diversification reduces risk from a single point of failure. Proceeds can fund exercise costs for remaining options. Tax planning is more controllable with a known transaction.

Arguments for waiting: With Anthropic already valued at $965B, the public-market price could be meaningfully higher or lower than the last private mark. Post-IPO, you have public market liquidity (after lockup). IPO investors often drive initial price momentum.

The framework answer: Sell enough in the tender to reach a minimum diversification threshold and fund any upcoming ISO exercise costs. Hold the rest for IPO upside. This way you've de-risked the catastrophic downside while maintaining exposure to the best-case scenario. The exact split depends on your total equity, concentration level, and near-term cash needs.

RSUs are taxed as ordinary income at vesting, based on the fair market value on the vesting date. Your employer withholds taxes by selling a portion of your shares, typically at a flat 22% federal rate (37% above $1M in supplemental wages), plus state taxes.

The problem: For most Anthropic employees, the real effective tax rate on RSU income is 40–50%+ (federal 35–37% + California 11.3–13.3% + Medicare 1.45% + NIIT 3.8%). A 22% withholding rate leaves a 20–30% gap that comes due in April as a lump-sum tax bill.

Example: 1,000 RSUs vest at $100/share FMV = $100,000 in ordinary income. Anthropic withholds ~$22,000 in federal taxes. Your actual federal liability is ~$37,000. Add California tax of ~$11,300 and you're short $26,300. That balance is due in April, when you may still not be able to sell shares to cover it.

Our RSU Tax Calculator models this gap precisely so you can make estimated payments quarterly instead of getting hit with a surprise bill.

This is one of the highest-stakes decisions Anthropic employees face, and it's often made without adequate advice. The answer depends on your cash position, risk tolerance, tax situation, and belief in Anthropic's trajectory.

ISOs favor you if: You have cash reserves to fund exercise costs and AMT, you can hold for LTCG qualification (1 year after exercise, 2 years after grant), and you believe the stock price will continue rising meaningfully. The tax savings between LTCG (23.8%) and ordinary income (50%+) on a large gain can be hundreds of thousands of dollars.

RSUs favor you if: You don't want to put cash at risk to exercise, you want certainty (shares just vest, with no exercise decision), or you're concerned about the company's long-term risk profile. RSUs are simpler but you lose the LTCG opportunity.

The real answer: Most employees should consult an advisor before making this election. The decision depends on your complete financial picture, and it's irreversible.

IPO preparation should start 12–18 months before the event, which means now if you believe 2026 is realistic. The employees who build wealth through IPOs are the ones who planned before the S-1 was filed, not the ones who reacted on listing day.

Pre-IPO checklist:

Exercise strategy: Begin tranche-exercising ISOs within the AMT-free zone now. Waiting until the IPO year concentrates all tax events into your highest-income year.

Cash reserves: Build a "tax war chest", meaning liquid savings earmarked for AMT payments, estimated taxes, and post-IPO tax obligations. The lockup period means you'll owe taxes before you can sell.

Post-lockup plan: Design your diversification schedule before the IPO, not during. Decide in advance what percentage you'll sell, on what timeline, and into what. Emotional decisions at the lockup expiry destroy wealth.

Estate planning: If your equity will exceed estate tax thresholds, gifting strategies using pre-IPO valuations can be dramatically more tax-efficient than post-IPO transfers.

After an IPO, employees typically face a lockup period of 90–180 days during which they cannot sell shares. Your options don't expire during this period, and you can usually still exercise, but you cannot sell the resulting shares.

The trap: If you exercise ISOs during or just before the lockup, the AMT event is triggered immediately, but you can't sell to cover the tax. If the stock price drops during the lockup (which happened to Uber, Snap, Lyft, and many others), you can end up owing taxes on gains that no longer exist.

The solution: Exercise before the IPO in controlled tranches, so the AMT event and your liquidity timeline aren't mismatched. Build cash reserves to cover taxes independently of share sales. And have a day-one post-lockup selling plan already designed.

The financial planning consensus is that any single position above 10–15% of total net worth introduces meaningful uncompensated risk. For Anthropic employees, the reality is that concentration is typically 70–95%, because that's what happens when you receive equity from a company whose valuation grew more than 15x in about two years.

The question isn't "should I diversify?". It's "how fast?" The answer depends on your critical mass: the amount of diversified, liquid wealth you need to sustain your lifestyle independently of Anthropic's stock price. Once you've reached critical mass, maintaining extreme concentration is no longer building wealth. It's gambling with wealth you've already earned.

Our Concentration Risk Analyzer stress-tests your portfolio against 30%, 50%, and 60% decline scenarios, which isn't hypothetical. Meta dropped 75% in 2022. Snap dropped 85% from its highs. Even great companies have violent drawdowns.

Believing in Anthropic and diversifying aren't contradictory. You can believe the company will succeed and still recognize that you're already over-exposed to that single outcome through your continued employment, future grants, and vested equity.

The asymmetric risk reality: If you have $3M in Anthropic equity and it doubles, your net worth goes from $3M to $6M, a meaningful upgrade, but not a life change. If it drops 50%, your net worth goes from $3M to $1.5M. That can delay retirement by a decade, change your housing plans, or eliminate your financial independence timeline entirely.

The AI industry is extraordinary, and extraordinarily competitive. Google, OpenAI, Meta, xAI, and dozens of well-funded startups are all building frontier models. Anthropic could win. It could also face revenue compression, margin erosion, or valuation re-rating. Diversification isn't a bet against Anthropic. It's a bet on your own financial resilience regardless of which AI company wins.